Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $42.4500 (0.21%) ($42.1400 - $43.5800) on Wed. Dec. 12, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.01% (three month average) | RSI | 73 | Latest Price | $42.4500(0.21%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 1% a day on average for past five trading days. | Weekly Trend | ATRA advances 4.6% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(58%) ARKG(51%) IBB(50%) IWO(50%) ARKK(48%) | Factors Impacting ATRA price | ATRA will decline at least -2.005% in a week (0% probabilities). VXX(-14%) TLT(-14%) VIXM(-13%) UUP(-11%) UNG(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.005% (StdDev 4.01%) | Hourly BBV | 0 () | Intraday Trend | -0.5% | | | |
|
5 Day Moving Average | $41.53(2.22%) | 10 Day Moving Average | $41.13(3.21%) | 20 Day Moving Average | $39(8.85%) | To recent high | -2.4% | To recent low | 34.3% | Market Cap | $3.154b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |